Both Th1 and Th2 cytokines affect the ability of monoclonal antibodies to protect mice against Cryptococcus neoformans

Infection and Immunity

Volumn 69, Issue 10, 2001, Pages 6445-6455

  Beenhouwer, D O ^a   Shapiro, S ^a   Feldmesser, M ^a   Casadevall, A ^a   Scharff, M D ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN G3; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 6; MONOCLONAL ANTIBODY; POLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; HUMORAL IMMUNITY; INFECTION RESISTANCE; INFECTION SENSITIVITY; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; SURVIVAL; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL;

ANIMALS; ANTIBODIES, FUNGAL; ANTIBODIES, MONOCLONAL; ANTIGENS, FUNGAL; CELLS, CULTURED; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; FEMALE; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN ISOTYPES; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-4; INTERLEUKIN-6; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHAGOCYTOSIS; POLYSACCHARIDES; TH1 CELLS; TH2 CELLS;

EID: 0034830978     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.10.6445-6455.2001     Document Type: Article

References (84)

1. Th1-Th2: Reliable paradigm or dangerous dogma?
2. Converging and diverging properties of human interleukin-4 and interleukin-10
3. Immune complex-induced interleukin-6, interleukin-10 and prostaglandin secretion by human monocytes: A network of pro- and anti-inflammatory cytokines dependent on the antigen:antibody ratio
4. Immune complexes are potent inhibitors of interleukin-12 secretion by human monocytes
5. Differential regulation of immune responses by highly and weakly virulent Cryptococcus neoformans isolates
6. Biomolecular events involved in anticryptococcal resistance in the brain
7. Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies
8. Antibodies elicited by a Cryptococcus neoformanstetanus toxoid conjugate vaccine have the same specificity as those elicited in infection
9. Monoclonal antibody based ELISAs for cryptococcal polysaccharide
10. Acquired immunodeficiency syndrome in African patients
11. Estimation of the prevalence of cryptococcal infection among patients infected with the human immunodeficiency virus in New York City
12. Both innate and acquired immunity to Listeria monocytogenes infection are increased in IL-10-deficient mice
13. Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: Correlation with inefficient neutrophilia
14. Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans
15. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production
16. Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody
17. Role of IgG and complement component C5 in the initial course of experimental cryptococcosis
18. Augmentation of the CD8+ T cell response by IFN-gamma in IL-12-deficient mice during Toxoplasma gondii infection
19. Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-Sepharose
20. HIV infection alters the production of both type 1 and 2 cytokines but does not induce a polarized type 1 or 2 state
21. Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection
22. Combination of 5-flucytosine and capsule-binding monoclonal antibody in the treatment of murine Cryptococcus neoformans infections and in vitro
23. Regulation of T helper cell responses in experimental murine schistosomiasis by IL-10. Effect on expression of B7 and B7-2 costimulatory molecules by macrophages
24. Microevolution of a standard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes
25. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha
26. CD4+ T cell-dependent acquired state of immunity that protects the brain against Cryptococcus neoformans
27. Interleukin 6 and its receptor: Ten years later
28. IL-12 and IFN-gamma are required for initiating the protective Th1 response to pulmonary cryptococcosis in resistant C.B-17 mice
29. Dissemination of C. neoformans to the central nervous system: Role of chemokines, Th1 immunity and leukocyte recruitment
30. Immunity to a pulmonary Cryptococcus neoformans infection requires both CD4+ and CDS+ T cells
31. T-cell-mediated immunity in the lung: A Cryptococcus neoformans pulmonary infection model using SCID and athymic nude mice
32. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi
33. Interleukin-4 weakens host resistance to pulmonary and disseminated cryptococcal infection caused by combined treatment with interferon-gamma-inducing cytokines
34. T cell-dependent activation of macrophages and enhancement of their phagocytic activity in the lungs of mice inoculated with heat-killed Cryptococcus neoformans: Involvement of IFN-gamma and its protective effect against cryptococcal infection
35. IL-12 protects mice against pulmonary and disseminated infection caused by Cryptococcus neoformans
36. Interleukin (IL)-12 deficiency in susceptible mice infected with Mycobacterium avium and amelioration of established infection by IL-12 replacement therapy
37. Impaired immune and acute-phase responses in interleukin-6-deficient mice
38. IL-4-deficient Balb/c mice resist infection with Leishmania major
39. Immune responses of IL-4, IL-5, IL-6 deficient mice
40. Interleukin-10-deficient mice develop chronic enterocolitis
41. Generation andanalysis of interleukin-4 deficient mice
42. Effect of immune mechanisms on the pharmacokinetics and organ distribution of cryptococcal polysaccharide
43. Cytokine profiles of AiDS patients are similar to those of mice with disseminated Cryptococcus neoformans infection
44. Ig heavy chain complex-linked genes influence the immune response in a murine cryptococcal infection
45. IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses
46. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response
47. IL-10 is required for development of protective Th1 responses in IL-12-deficient mice upon Candida albicans infection
48. Endogenous interleukin 4 is required for development of protective CD4+ T helper type 1 cell responses to Candida albicans
49. Monoclonal antibodies reveal additional epitopes of serotype D Cryptococcus neoformans capsular glucuronoxylomannan that elicit protective antibodies
50. Protective and nonprotective monoclonal antibodies to Cryptococcus neoformans originating from one B cell
51. Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection
52. Protective murine monoclonal antibodies to Cryptococcus neoformans
53. Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B
54. Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice
55. Antibodies to Cryptococcus neoformans glucuronoxylomannan enhance antifungal activity of murine macrophages
56. Interleukin-4-deficient mice
57. Revisiting the Th1/Th2 paradigm
58. Increased antimycobacterial immunity in interleukin-10-deficient mice
59. Susceptibility to Leishmania major infection in interleukin-4-deficient mice
60. Immunoglobulin G3 blocking antibodies to the fungal pathogen Cryptococcus neoformans
61. Recent advances in the management of cryptococcal meningitis in patients with AIDS
62. IL-10 and viral IL-10 prevent IL-4-induced IgE synthesis by inhibiting the accessory cell function of monocytes
63. Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells
64. Different roles for interleukin-4 during the course of Toxoplasma gondii infection
65. The Th1/Th2 paradigm
66. B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10
67. Identification of rare immunoglobulin switch variants using the ELISA spot assay
68. Increase in plasma IL-10 levels and rapid loss of CD4+ T cells among HIV-infected individuals in south India
69. Interleukin-10 as a regulatory cytokine induced by cellular stress: Molecular aspects
70. IL-10 in HIV infection: Increasing serum IL-10 levels with disease progression - Down-regulatory effect of potent anti-retroviral therapy
71. IL-4 is protective against development of toxoplasmic encephalitis
72. IL-10 stimulates monocyte Fc gamma R surface expression and cytotoxic activity. Distinct regulation of antibody-dependent cellular cytotoxicity by IFN-gamma, IL-4, and IL-10
73. Immune complexes inhibit antimicrobial responses through interleukin-10 production. Effects in severe combined immunodeficient mice during Listeria infection
74. IL-4 and IL-10 antagonize IL-12-mediated protection against acute vaccinia virus infection with a limited role of IFN-gamma and nitric oxide synthetase 2
75. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome
76. Early resistance of interleukin-10 knockout mice to acute systemic candidiasis
77. Production of IL-5 by human NK cells and regulation of IL-5 secretion by IL-4, IL-10, and IL-12
78. Isotype switching from IgG3 to IgG1 converts a nonprotective murine antibody to Cryptococcus neoformans into a protective antibody
79. Antibody-mediated modulation of Cryptococcus neoformans infection is dependent on distinct Fc receptor functions and IgG subclasses
80. T cells cooperate with passive antibody to modify Cryptococcus neoformans infection in mice
81. Isotype switching increases efficacy of antibody protection against Cryptococcus neoformans infection in mice
82. Modulation by IL-10 of antigen-induced IL-5 generation, and CD4+ T lymphocyte and eosinophil infiltration into the mouse peritoneal cavity
83. Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment